ERBB2 and breast carcinoma: ERα and progesterone (PR) expression was first analyzed by Western in six different cell lines representative of hormone receptor positive (MCF7, T47D), HER2 positive (SKBR3, BT474), and triple-negative (MDA-MB231, HS578T) breast cancer subtypes.